Latest filing published 17 Jan 2012 for Pharmasset Inc, €67.6M.
No signal scores available.
P. Schaefer Price discloses dealings in Pharmasset Inc to SEC (Form 4). We count 13 filings; the first trade dates from 1 June 2011 and the latest from 12 January 2012.
On the market, this insider has only sold: 5 sales, €8.9M in total. Outside the open market, there are 5 option exercises.
On 17 January 2012 came the latest disclosure, a transaction for €7.5M in Pharmasset Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 of 12 declarations